Cargando…

Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism

CONTEXT: Non-alcoholic fatty liver disease (NAFLD) is a leading causes of liver-related morbidity and mortality. While data on acromegaly, a state of chronic growth hormone (GH)/insulin-like growth factor I (IGF-I) excess, suggest an inverse relationship with intrahepatic lipid (IHL) content, less i...

Descripción completa

Detalles Bibliográficos
Autores principales: Fellinger, Paul, Beiglböck, Hannes, Semmler, Georg, Pfleger, Lorenz, Smajis, Sabina, Baumgartner, Clemens, Gajdosik, Martin, Marculescu, Rodrig, Vila, Greisa, Winhofer, Yvonne, Scherer, Thomas, Trauner, Michael, Kautzky-Willer, Alexandra, Krssak, Martin, Krebs, Michael, Wolf, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505545/
https://www.ncbi.nlm.nih.gov/pubmed/37104943
http://dx.doi.org/10.1210/clinem/dgad206
_version_ 1785106933012758528
author Fellinger, Paul
Beiglböck, Hannes
Semmler, Georg
Pfleger, Lorenz
Smajis, Sabina
Baumgartner, Clemens
Gajdosik, Martin
Marculescu, Rodrig
Vila, Greisa
Winhofer, Yvonne
Scherer, Thomas
Trauner, Michael
Kautzky-Willer, Alexandra
Krssak, Martin
Krebs, Michael
Wolf, Peter
author_facet Fellinger, Paul
Beiglböck, Hannes
Semmler, Georg
Pfleger, Lorenz
Smajis, Sabina
Baumgartner, Clemens
Gajdosik, Martin
Marculescu, Rodrig
Vila, Greisa
Winhofer, Yvonne
Scherer, Thomas
Trauner, Michael
Kautzky-Willer, Alexandra
Krssak, Martin
Krebs, Michael
Wolf, Peter
author_sort Fellinger, Paul
collection PubMed
description CONTEXT: Non-alcoholic fatty liver disease (NAFLD) is a leading causes of liver-related morbidity and mortality. While data on acromegaly, a state of chronic growth hormone (GH)/insulin-like growth factor I (IGF-I) excess, suggest an inverse relationship with intrahepatic lipid (IHL) content, less is known about the impact of the GH/IGF-I axis on IHL, lipid composition, and phosphor metabolites in individuals without disorders of GH secretion. OBJECTIVE: The aim was to investigate the relation between activity of the GH/IGF-I axis and IHL content and phosphor metabolism. METHODS: We performed a cross-sectional study in 59 otherwise metabolically healthy individuals (30 females), of which 16 met the criteria of NAFLD with IHL of ≥5.6%. The GH/IGF-I axis was evaluated in a fasting state and during an oral glucose tolerance test (OGTT). Insulin sensitivity was estimated by validated indices. IHL, lipid composition (unsaturation index), and phosphate metabolites were analyzed by using (1)H/(31)P magnetic resonance spectroscopy. RESULTS: In the overall cohort (40.6 ± 15 years; body mass index: 24.5 ± 3 kg/m(2); IGF-I: 68.0 ± 17% upper limit of normal), fasting GH (R = −0.31; P = .02), GH during oral glucose tolerance test (R = −0.51; P < .01), and IGF-I (R = −0.28; P = .03) inversely correlated with IHL. GH levels during OGTT were significantly lower in NAFLD than in controls (47.7 [22; 143] ng/mL/min vs 16.8 [7; 32] ng/mL/min; P = .003). GH/IGF-I axis activity correlated with lipid composition and with phosphor metabolites. In multiple regression analysis, the GH/IGF-I axis activity was a strong predictor for IHL and lipid composition independent from insulin sensitivity. CONCLUSION: GH/IGF-I axis activity impacts hepatic lipid and phosphate metabolism in individuals without disorders in GH secretion. Lower GH axis activity is associated with higher IHL and an unfavorable lipid composition, probably mediated by changes in hepatic energy metabolism.
format Online
Article
Text
id pubmed-10505545
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105055452023-09-19 Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism Fellinger, Paul Beiglböck, Hannes Semmler, Georg Pfleger, Lorenz Smajis, Sabina Baumgartner, Clemens Gajdosik, Martin Marculescu, Rodrig Vila, Greisa Winhofer, Yvonne Scherer, Thomas Trauner, Michael Kautzky-Willer, Alexandra Krssak, Martin Krebs, Michael Wolf, Peter J Clin Endocrinol Metab Clinical Research Article CONTEXT: Non-alcoholic fatty liver disease (NAFLD) is a leading causes of liver-related morbidity and mortality. While data on acromegaly, a state of chronic growth hormone (GH)/insulin-like growth factor I (IGF-I) excess, suggest an inverse relationship with intrahepatic lipid (IHL) content, less is known about the impact of the GH/IGF-I axis on IHL, lipid composition, and phosphor metabolites in individuals without disorders of GH secretion. OBJECTIVE: The aim was to investigate the relation between activity of the GH/IGF-I axis and IHL content and phosphor metabolism. METHODS: We performed a cross-sectional study in 59 otherwise metabolically healthy individuals (30 females), of which 16 met the criteria of NAFLD with IHL of ≥5.6%. The GH/IGF-I axis was evaluated in a fasting state and during an oral glucose tolerance test (OGTT). Insulin sensitivity was estimated by validated indices. IHL, lipid composition (unsaturation index), and phosphate metabolites were analyzed by using (1)H/(31)P magnetic resonance spectroscopy. RESULTS: In the overall cohort (40.6 ± 15 years; body mass index: 24.5 ± 3 kg/m(2); IGF-I: 68.0 ± 17% upper limit of normal), fasting GH (R = −0.31; P = .02), GH during oral glucose tolerance test (R = −0.51; P < .01), and IGF-I (R = −0.28; P = .03) inversely correlated with IHL. GH levels during OGTT were significantly lower in NAFLD than in controls (47.7 [22; 143] ng/mL/min vs 16.8 [7; 32] ng/mL/min; P = .003). GH/IGF-I axis activity correlated with lipid composition and with phosphor metabolites. In multiple regression analysis, the GH/IGF-I axis activity was a strong predictor for IHL and lipid composition independent from insulin sensitivity. CONCLUSION: GH/IGF-I axis activity impacts hepatic lipid and phosphate metabolism in individuals without disorders in GH secretion. Lower GH axis activity is associated with higher IHL and an unfavorable lipid composition, probably mediated by changes in hepatic energy metabolism. Oxford University Press 2023-04-27 /pmc/articles/PMC10505545/ /pubmed/37104943 http://dx.doi.org/10.1210/clinem/dgad206 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Research Article
Fellinger, Paul
Beiglböck, Hannes
Semmler, Georg
Pfleger, Lorenz
Smajis, Sabina
Baumgartner, Clemens
Gajdosik, Martin
Marculescu, Rodrig
Vila, Greisa
Winhofer, Yvonne
Scherer, Thomas
Trauner, Michael
Kautzky-Willer, Alexandra
Krssak, Martin
Krebs, Michael
Wolf, Peter
Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism
title Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism
title_full Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism
title_fullStr Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism
title_full_unstemmed Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism
title_short Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism
title_sort increased gh/igf-i axis activity relates to lower hepatic lipids and phosphor metabolism
topic Clinical Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505545/
https://www.ncbi.nlm.nih.gov/pubmed/37104943
http://dx.doi.org/10.1210/clinem/dgad206
work_keys_str_mv AT fellingerpaul increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism
AT beiglbockhannes increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism
AT semmlergeorg increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism
AT pflegerlorenz increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism
AT smajissabina increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism
AT baumgartnerclemens increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism
AT gajdosikmartin increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism
AT marculescurodrig increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism
AT vilagreisa increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism
AT winhoferyvonne increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism
AT schererthomas increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism
AT traunermichael increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism
AT kautzkywilleralexandra increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism
AT krssakmartin increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism
AT krebsmichael increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism
AT wolfpeter increasedghigfiaxisactivityrelatestolowerhepaticlipidsandphosphormetabolism